首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Exploration of targeted antitumor therapy

缩写:

ISSN:2692-3114

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引375
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Dakota Dike Dimegwu Okwuone,Deri Morgan,Gregory N Gan Dakota Dike Dimegwu Okwuone
Head and neck cancer (HNC) is a challenging disease that lacks effective treatment, particularly in the cases that spread locoregionally and metastasize distantly, dramatically reducing patient survival rates. Expanding the understanding of...
Cassidy M Van Stiphout,Grant Kelly,Nikitha K Pallegar et al. Cassidy M Van Stiphout et al.
Aim: Breast cancer (BC) is the most common cancer in women worldwide, where adiposity has been linked to BC morbidity. In general, obese premenopausal women diagnosed with triple-negative BC (TNBC) tend to have larger tum...
Zachary Hamel,Sierra Sanchez,David Standing et al. Zachary Hamel et al.
Pancreatic cancer remains a serious and deadly disease, impacting people globally. There remain prominent gaps in the current understanding of the disease, specifically regarding the role of the signal transducer and activator of transcript...
Jingxin Ye,Jianfeng Zhang,Weifeng Ding Jingxin Ye
Colorectal cancer (CRC) is a multifaceted disease influenced by the interplay of genetic and environmental factors. The clinical heterogeneity of CRC cannot be attributed exclusively to genetic diversity and environmental exposures, and epi...
Pierluigi De Santis,Martina Perrone,Chiara Guarini et al. Pierluigi De Santis et al.
Triple negative breast cancer (TNBC) represents an aggressive disease associated with a high risk of recurrence after curative treatment and a poor prognosis in the metastatic setting. Chemotherapy was for years the only treatment available...
George Pears,Abhishek Mahajan,Anna Olsson-Brown et al. George Pears et al.
Immunotherapy treatments for cancer are known to cause adverse thyroid events which present a diagnostic challenge to clinicians and radiologists. This case report highlights the importance of a high clinical index of suspicion and careful ...
Eric Jou,Natasha Chaudhury,Fizza Nasim Eric Jou
Cancer is the leading cause of death globally superseded only by cardiovascular diseases, and novel strategies to overcome therapeutic resistance against existing cancer treatments are urgently required. Myeloid-derived suppressor cells (MD...
Agustiningsih Agustiningsih,Muhammad Rezki Rasyak,Turyadi et al. Agustiningsih Agustiningsih et al.
Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancers with high mortality rate. Among its various etiological factors, one of the major risk factors for HCC is a chronic infection of hepatitis B virus (HBV). HBV...
Hiroki Goto,Yoshioki Shiraishi,Seiji Okada Hiroki Goto
Radioimmunotherapy (RIT) is a therapy that combines a radioactive nucleotide with a monoclonal antibody (mAb). RIT enhances the therapeutic effect of mAb and reduces toxicity compared with conventional treatment. The purpose of this review ...
Tomas Koltai,Larry Fliegel Tomas Koltai
Cells are separated from the environment by a lipid bilayer membrane that is relatively impermeable to solutes. The transport of ions and small molecules across this membrane is an essential process in cell biology and metabolism. Monocarbo...